カテゴリー： 世界, 医療/バイオ, LP Information

世界の乳房病変位置同定装置市場予測 2023年-2029年

【英語タイトル】Global Breast Lesion Localization Systems Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4249）・商品コード：LP23MY4249
・発行会社（調査会社）：LP Information
・発行日：2023年5月（※2025年版があります。お問い合わせください。）
・ページ数：102
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の乳房病変位置同定装置市場」は、過去の販売実績から2022年の世界の乳房病変位置同定装置の総販売量を検討し、2023年から2029年の予測される乳房病変位置同定装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の乳房病変位置同定装置の市場規模を掲載し、XXX百万米ドル規模の世界の乳房病変位置同定装置市場の詳細な分析を提供します。本インサイトレポートは、世界の乳房病変位置同定装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の乳房病変位置同定装置市場における各社の独自のポジションをより深く理解するために、乳房病変位置同定装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の乳房病変位置同定装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。乳房病変位置同定装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。乳房病変位置同定装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。乳房病変位置同定装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

乳房病変位置同定装置の世界主要メーカーとしては、BD、 IZI Medical、 Merit Medical、 Argon Medical Devices、 Theragenics、 Hologic、 IsoAid、 Endomag、 Ranfac、 STERYLAB、 Biomedicalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の乳房病変位置同定装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では乳房病変位置同定装置市場をセグメンテーションし、種類別 (ワイヤー型乳房病変位置同定装置、ワイヤレス型乳房病変位置同定装置)、用途別 (病院、診療所、医療研究センター、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ワイヤー型乳房病変位置同定装置、ワイヤレス型乳房病変位置同定装置

・用途別区分：病院、診療所、医療研究センター、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の乳房病変位置同定装置市場の10年間の市場状況・展望は？
・世界および地域別に見た乳房病変位置同定装置市場成長の要因は何か？
・乳房病変位置同定装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・乳房病変位置同定装置のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：乳房病変位置同定装置の年間販売量2018-2029、地域別現状・将来分析
・乳房病変位置同定装置の種類別セグメント：ワイヤー型乳房病変位置同定装置、ワイヤレス型乳房病変位置同定装置
・乳房病変位置同定装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・乳房病変位置同定装置の用途別セグメント：病院、診療所、医療研究センター、その他
・乳房病変位置同定装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の乳房病変位置同定装置市場
・企業別のグローバル乳房病変位置同定装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別の乳房病変位置同定装置の年間売上：2018-2023年の売上、市場シェア
・企業別の乳房病変位置同定装置販売価格
・主要企業の乳房病変位置同定装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

乳房病変位置同定装置の地域別レビュー
・地域別の乳房病変位置同定装置市場規模2018-2023：年間販売量、売上
・主要国別の乳房病変位置同定装置市場規模2018-2023：年間販売量、売上
・南北アメリカの乳房病変位置同定装置販売の成長
・アジア太平洋の乳房病変位置同定装置販売の成長
・ヨーロッパの乳房病変位置同定装置販売の成長
・中東・アフリカの乳房病変位置同定装置販売の成長

南北アメリカ市場
・南北アメリカの国別の乳房病変位置同定装置販売量、売上（2018-2023）
・南北アメリカの乳房病変位置同定装置の種類別販売量
・南北アメリカの乳房病変位置同定装置の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の乳房病変位置同定装置販売量、売上（2018-2023）
・アジア太平洋の乳房病変位置同定装置の種類別販売量
・アジア太平洋の乳房病変位置同定装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の乳房病変位置同定装置販売量、売上（2018-2023）
・ヨーロッパの乳房病変位置同定装置の種類別販売量
・ヨーロッパの乳房病変位置同定装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の乳房病変位置同定装置販売量、売上（2018-2023）
・中東・アフリカの乳房病変位置同定装置の種類別販売量
・中東・アフリカの乳房病変位置同定装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・乳房病変位置同定装置の製造コスト構造分析
・乳房病変位置同定装置の製造プロセス分析
・乳房病変位置同定装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・乳房病変位置同定装置の主要なグローバル販売業者
・乳房病変位置同定装置の主要なグローバル顧客

地域別の乳房病変位置同定装置市場予測レビュー
・地域別の乳房病変位置同定装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・乳房病変位置同定装置の種類別市場規模予測
・乳房病変位置同定装置の用途別市場規模予測

主要企業分析
BD、 IZI Medical、 Merit Medical、 Argon Medical Devices、 Theragenics、 Hologic、 IsoAid、 Endomag、 Ranfac、 STERYLAB、 Biomedical
・企業情報
・乳房病変位置同定装置製品
・乳房病変位置同定装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

As preparation for surgery to breast disease, patients may be asked by their surgeon to undergo breast localization at the Breast Diagnostic Center. This procedure utilizes imaging to mark the edges of the tumor or lesion to be removed – enabling the greatest degree of surgical accuracy and aids removal of the tumor or lesion with the smallest possible incision.
For decades, wire localization has been the standard for preoperative localization in breast imaging. With this method, a wire is placed in the breast percutaneously, with the distal wire segment positioned adjacent to the abnormality and the proximal wire segment remaining outside the breast. Because of the external component of the wire, the patient must be compliant, and care must be taken to not disturb the wire’s position before surgery. Scheduling flexibility is also limited because the wire localization must be performed on the same day as the subsequent surgery. More recently, the available options for performing preoperative localization have expanded greatly and now include the use of nonwire devices such as radioactive and magnetic seeds, radar reflectors, and radiofrequency identification tags. Nonwire localization devices can be placed days in advance of the surgery, at the patient’s convenience, to avoid wire-related challenges and complications. They are placed percutaneously within or adjacent to the target breast lesion and detected intraoperatively by using a probe outside the breast.
LPI (LP Information)’ newest research report, the “Breast Lesion Localization Systems Industry Forecast” looks at past sales and reviews total world Breast Lesion Localization Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Breast Lesion Localization Systems sales for 2023 through 2029. With Breast Lesion Localization Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast Lesion Localization Systems industry.
This Insight Report provides a comprehensive analysis of the global Breast Lesion Localization Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breast Lesion Localization Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breast Lesion Localization Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast Lesion Localization Systems and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast Lesion Localization Systems.
The global Breast Lesion Localization Systems market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Breast Lesion Localization Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Breast Lesion Localization Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Breast Lesion Localization Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Breast Lesion Localization Systems players cover BD, IZI Medical, Merit Medical, Argon Medical Devices, Theragenics, Hologic, IsoAid, Endomag and Ranfac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Breast Lesion Localization Systems market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Breast Lesion Localization Wired Systems
Breast Lesion Localization Wireless Systems
Segmentation by application
Hospital
Clinic
Medical Research Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
BD
IZI Medical
Merit Medical
Argon Medical Devices
Theragenics
Hologic
IsoAid
Endomag
Ranfac
STERYLAB
Biomedical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Breast Lesion Localization Systems market?
What factors are driving Breast Lesion Localization Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Breast Lesion Localization Systems market opportunities vary by end market size?
How does Breast Lesion Localization Systems break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Breast Lesion Localization Systems Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Breast Lesion Localization Systems by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Breast Lesion Localization Systems by Country/Region, 2018, 2022 & 2029
2.2 Breast Lesion Localization Systems Segment by Type
2.2.1 Breast Lesion Localization Wired Systems
2.2.2 Breast Lesion Localization Wireless Systems
2.3 Breast Lesion Localization Systems Sales by Type
2.3.1 Global Breast Lesion Localization Systems Sales Market Share by Type (2018-2023)
2.3.2 Global Breast Lesion Localization Systems Revenue and Market Share by Type (2018-2023)
2.3.3 Global Breast Lesion Localization Systems Sale Price by Type (2018-2023)
2.4 Breast Lesion Localization Systems Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Medical Research Center
2.4.4 Others
2.5 Breast Lesion Localization Systems Sales by Application
2.5.1 Global Breast Lesion Localization Systems Sale Market Share by Application (2018-2023)
2.5.2 Global Breast Lesion Localization Systems Revenue and Market Share by Application (2018-2023)
2.5.3 Global Breast Lesion Localization Systems Sale Price by Application (2018-2023)
3 Global Breast Lesion Localization Systems by Company
3.1 Global Breast Lesion Localization Systems Breakdown Data by Company
3.1.1 Global Breast Lesion Localization Systems Annual Sales by Company (2018-2023)
3.1.2 Global Breast Lesion Localization Systems Sales Market Share by Company (2018-2023)
3.2 Global Breast Lesion Localization Systems Annual Revenue by Company (2018-2023)
3.2.1 Global Breast Lesion Localization Systems Revenue by Company (2018-2023)
3.2.2 Global Breast Lesion Localization Systems Revenue Market Share by Company (2018-2023)
3.3 Global Breast Lesion Localization Systems Sale Price by Company
3.4 Key Manufacturers Breast Lesion Localization Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Breast Lesion Localization Systems Product Location Distribution
3.4.2 Players Breast Lesion Localization Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Breast Lesion Localization Systems by Geographic Region
4.1 World Historic Breast Lesion Localization Systems Market Size by Geographic Region (2018-2023)
4.1.1 Global Breast Lesion Localization Systems Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Breast Lesion Localization Systems Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Breast Lesion Localization Systems Market Size by Country/Region (2018-2023)
4.2.1 Global Breast Lesion Localization Systems Annual Sales by Country/Region (2018-2023)
4.2.2 Global Breast Lesion Localization Systems Annual Revenue by Country/Region (2018-2023)
4.3 Americas Breast Lesion Localization Systems Sales Growth
4.4 APAC Breast Lesion Localization Systems Sales Growth
4.5 Europe Breast Lesion Localization Systems Sales Growth
4.6 Middle East & Africa Breast Lesion Localization Systems Sales Growth
5 Americas
5.1 Americas Breast Lesion Localization Systems Sales by Country
5.1.1 Americas Breast Lesion Localization Systems Sales by Country (2018-2023)
5.1.2 Americas Breast Lesion Localization Systems Revenue by Country (2018-2023)
5.2 Americas Breast Lesion Localization Systems Sales by Type
5.3 Americas Breast Lesion Localization Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Breast Lesion Localization Systems Sales by Region
6.1.1 APAC Breast Lesion Localization Systems Sales by Region (2018-2023)
6.1.2 APAC Breast Lesion Localization Systems Revenue by Region (2018-2023)
6.2 APAC Breast Lesion Localization Systems Sales by Type
6.3 APAC Breast Lesion Localization Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Breast Lesion Localization Systems by Country
7.1.1 Europe Breast Lesion Localization Systems Sales by Country (2018-2023)
7.1.2 Europe Breast Lesion Localization Systems Revenue by Country (2018-2023)
7.2 Europe Breast Lesion Localization Systems Sales by Type
7.3 Europe Breast Lesion Localization Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Breast Lesion Localization Systems by Country
8.1.1 Middle East & Africa Breast Lesion Localization Systems Sales by Country (2018-2023)
8.1.2 Middle East & Africa Breast Lesion Localization Systems Revenue by Country (2018-2023)
8.2 Middle East & Africa Breast Lesion Localization Systems Sales by Type
8.3 Middle East & Africa Breast Lesion Localization Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Breast Lesion Localization Systems
10.3 Manufacturing Process Analysis of Breast Lesion Localization Systems
10.4 Industry Chain Structure of Breast Lesion Localization Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Breast Lesion Localization Systems Distributors
11.3 Breast Lesion Localization Systems Customer
12 World Forecast Review for Breast Lesion Localization Systems by Geographic Region
12.1 Global Breast Lesion Localization Systems Market Size Forecast by Region
12.1.1 Global Breast Lesion Localization Systems Forecast by Region (2024-2029)
12.1.2 Global Breast Lesion Localization Systems Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Breast Lesion Localization Systems Forecast by Type
12.7 Global Breast Lesion Localization Systems Forecast by Application
13 Key Players Analysis
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Breast Lesion Localization Systems Product Portfolios and Specifications
13.1.3 BD Breast Lesion Localization Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 IZI Medical
13.2.1 IZI Medical Company Information
13.2.2 IZI Medical Breast Lesion Localization Systems Product Portfolios and Specifications
13.2.3 IZI Medical Breast Lesion Localization Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 IZI Medical Main Business Overview
13.2.5 IZI Medical Latest Developments
13.3 Merit Medical
13.3.1 Merit Medical Company Information
13.3.2 Merit Medical Breast Lesion Localization Systems Product Portfolios and Specifications
13.3.3 Merit Medical Breast Lesion Localization Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merit Medical Main Business Overview
13.3.5 Merit Medical Latest Developments
13.4 Argon Medical Devices
13.4.1 Argon Medical Devices Company Information
13.4.2 Argon Medical Devices Breast Lesion Localization Systems Product Portfolios and Specifications
13.4.3 Argon Medical Devices Breast Lesion Localization Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Argon Medical Devices Main Business Overview
13.4.5 Argon Medical Devices Latest Developments
13.5 Theragenics
13.5.1 Theragenics Company Information
13.5.2 Theragenics Breast Lesion Localization Systems Product Portfolios and Specifications
13.5.3 Theragenics Breast Lesion Localization Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Theragenics Main Business Overview
13.5.5 Theragenics Latest Developments
13.6 Hologic
13.6.1 Hologic Company Information
13.6.2 Hologic Breast Lesion Localization Systems Product Portfolios and Specifications
13.6.3 Hologic Breast Lesion Localization Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hologic Main Business Overview
13.6.5 Hologic Latest Developments
13.7 IsoAid
13.7.1 IsoAid Company Information
13.7.2 IsoAid Breast Lesion Localization Systems Product Portfolios and Specifications
13.7.3 IsoAid Breast Lesion Localization Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 IsoAid Main Business Overview
13.7.5 IsoAid Latest Developments
13.8 Endomag
13.8.1 Endomag Company Information
13.8.2 Endomag Breast Lesion Localization Systems Product Portfolios and Specifications
13.8.3 Endomag Breast Lesion Localization Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Endomag Main Business Overview
13.8.5 Endomag Latest Developments
13.9 Ranfac
13.9.1 Ranfac Company Information
13.9.2 Ranfac Breast Lesion Localization Systems Product Portfolios and Specifications
13.9.3 Ranfac Breast Lesion Localization Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ranfac Main Business Overview
13.9.5 Ranfac Latest Developments
13.10 STERYLAB
13.10.1 STERYLAB Company Information
13.10.2 STERYLAB Breast Lesion Localization Systems Product Portfolios and Specifications
13.10.3 STERYLAB Breast Lesion Localization Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 STERYLAB Main Business Overview
13.10.5 STERYLAB Latest Developments
13.11 Biomedical
13.11.1 Biomedical Company Information
13.11.2 Biomedical Breast Lesion Localization Systems Product Portfolios and Specifications
13.11.3 Biomedical Breast Lesion Localization Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Biomedical Main Business Overview
13.11.5 Biomedical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Breast Lesion Localization Systems Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Breast Lesion Localization Systems Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Breast Lesion Localization Wired Systems
Table 4. Major Players of Breast Lesion Localization Wireless Systems
Table 5. Global Breast Lesion Localization Systems Sales by Type (2018-2023) & (K Units)
Table 6. Global Breast Lesion Localization Systems Sales Market Share by Type (2018-2023)
Table 7. Global Breast Lesion Localization Systems Revenue by Type (2018-2023) & ($ million)
Table 8. Global Breast Lesion Localization Systems Revenue Market Share by Type (2018-2023)
Table 9. Global Breast Lesion Localization Systems Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Breast Lesion Localization Systems Sales by Application (2018-2023) & (K Units)
Table 11. Global Breast Lesion Localization Systems Sales Market Share by Application (2018-2023)
Table 12. Global Breast Lesion Localization Systems Revenue by Application (2018-2023)
Table 13. Global Breast Lesion Localization Systems Revenue Market Share by Application (2018-2023)
Table 14. Global Breast Lesion Localization Systems Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Breast Lesion Localization Systems Sales by Company (2018-2023) & (K Units)
Table 16. Global Breast Lesion Localization Systems Sales Market Share by Company (2018-2023)
Table 17. Global Breast Lesion Localization Systems Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Breast Lesion Localization Systems Revenue Market Share by Company (2018-2023)
Table 19. Global Breast Lesion Localization Systems Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Breast Lesion Localization Systems Producing Area Distribution and Sales Area
Table 21. Players Breast Lesion Localization Systems Products Offered
Table 22. Breast Lesion Localization Systems Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Breast Lesion Localization Systems Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Breast Lesion Localization Systems Sales Market Share Geographic Region (2018-2023)
Table 27. Global Breast Lesion Localization Systems Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Breast Lesion Localization Systems Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Breast Lesion Localization Systems Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Breast Lesion Localization Systems Sales Market Share by Country/Region (2018-2023)
Table 31. Global Breast Lesion Localization Systems Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Breast Lesion Localization Systems Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Breast Lesion Localization Systems Sales by Country (2018-2023) & (K Units)
Table 34. Americas Breast Lesion Localization Systems Sales Market Share by Country (2018-2023)
Table 35. Americas Breast Lesion Localization Systems Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Breast Lesion Localization Systems Revenue Market Share by Country (2018-2023)
Table 37. Americas Breast Lesion Localization Systems Sales by Type (2018-2023) & (K Units)
Table 38. Americas Breast Lesion Localization Systems Sales by Application (2018-2023) & (K Units)
Table 39. APAC Breast Lesion Localization Systems Sales by Region (2018-2023) & (K Units)
Table 40. APAC Breast Lesion Localization Systems Sales Market Share by Region (2018-2023)
Table 41. APAC Breast Lesion Localization Systems Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Breast Lesion Localization Systems Revenue Market Share by Region (2018-2023)
Table 43. APAC Breast Lesion Localization Systems Sales by Type (2018-2023) & (K Units)
Table 44. APAC Breast Lesion Localization Systems Sales by Application (2018-2023) & (K Units)
Table 45. Europe Breast Lesion Localization Systems Sales by Country (2018-2023) & (K Units)
Table 46. Europe Breast Lesion Localization Systems Sales Market Share by Country (2018-2023)
Table 47. Europe Breast Lesion Localization Systems Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Breast Lesion Localization Systems Revenue Market Share by Country (2018-2023)
Table 49. Europe Breast Lesion Localization Systems Sales by Type (2018-2023) & (K Units)
Table 50. Europe Breast Lesion Localization Systems Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Breast Lesion Localization Systems Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Breast Lesion Localization Systems Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Breast Lesion Localization Systems Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Breast Lesion Localization Systems Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Breast Lesion Localization Systems Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Breast Lesion Localization Systems Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Breast Lesion Localization Systems
Table 58. Key Market Challenges & Risks of Breast Lesion Localization Systems
Table 59. Key Industry Trends of Breast Lesion Localization Systems
Table 60. Breast Lesion Localization Systems Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Breast Lesion Localization Systems Distributors List
Table 63. Breast Lesion Localization Systems Customer List
Table 64. Global Breast Lesion Localization Systems Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Breast Lesion Localization Systems Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Breast Lesion Localization Systems Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Breast Lesion Localization Systems Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Breast Lesion Localization Systems Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Breast Lesion Localization Systems Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Breast Lesion Localization Systems Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Breast Lesion Localization Systems Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Breast Lesion Localization Systems Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Breast Lesion Localization Systems Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Breast Lesion Localization Systems Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Breast Lesion Localization Systems Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Breast Lesion Localization Systems Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Breast Lesion Localization Systems Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. BD Basic Information, Breast Lesion Localization Systems Manufacturing Base, Sales Area and Its Competitors
Table 79. BD Breast Lesion Localization Systems Product Portfolios and Specifications
Table 80. BD Breast Lesion Localization Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. BD Main Business
Table 82. BD Latest Developments
Table 83. IZI Medical Basic Information, Breast Lesion Localization Systems Manufacturing Base, Sales Area and Its Competitors
Table 84. IZI Medical Breast Lesion Localization Systems Product Portfolios and Specifications
Table 85. IZI Medical Breast Lesion Localization Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. IZI Medical Main Business
Table 87. IZI Medical Latest Developments
Table 88. Merit Medical Basic Information, Breast Lesion Localization Systems Manufacturing Base, Sales Area and Its Competitors
Table 89. Merit Medical Breast Lesion Localization Systems Product Portfolios and Specifications
Table 90. Merit Medical Breast Lesion Localization Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Merit Medical Main Business
Table 92. Merit Medical Latest Developments
Table 93. Argon Medical Devices Basic Information, Breast Lesion Localization Systems Manufacturing Base, Sales Area and Its Competitors
Table 94. Argon Medical Devices Breast Lesion Localization Systems Product Portfolios and Specifications
Table 95. Argon Medical Devices Breast Lesion Localization Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Argon Medical Devices Main Business
Table 97. Argon Medical Devices Latest Developments
Table 98. Theragenics Basic Information, Breast Lesion Localization Systems Manufacturing Base, Sales Area and Its Competitors
Table 99. Theragenics Breast Lesion Localization Systems Product Portfolios and Specifications
Table 100. Theragenics Breast Lesion Localization Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Theragenics Main Business
Table 102. Theragenics Latest Developments
Table 103. Hologic Basic Information, Breast Lesion Localization Systems Manufacturing Base, Sales Area and Its Competitors
Table 104. Hologic Breast Lesion Localization Systems Product Portfolios and Specifications
Table 105. Hologic Breast Lesion Localization Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Hologic Main Business
Table 107. Hologic Latest Developments
Table 108. IsoAid Basic Information, Breast Lesion Localization Systems Manufacturing Base, Sales Area and Its Competitors
Table 109. IsoAid Breast Lesion Localization Systems Product Portfolios and Specifications
Table 110. IsoAid Breast Lesion Localization Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. IsoAid Main Business
Table 112. IsoAid Latest Developments
Table 113. Endomag Basic Information, Breast Lesion Localization Systems Manufacturing Base, Sales Area and Its Competitors
Table 114. Endomag Breast Lesion Localization Systems Product Portfolios and Specifications
Table 115. Endomag Breast Lesion Localization Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Endomag Main Business
Table 117. Endomag Latest Developments
Table 118. Ranfac Basic Information, Breast Lesion Localization Systems Manufacturing Base, Sales Area and Its Competitors
Table 119. Ranfac Breast Lesion Localization Systems Product Portfolios and Specifications
Table 120. Ranfac Breast Lesion Localization Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Ranfac Main Business
Table 122. Ranfac Latest Developments
Table 123. STERYLAB Basic Information, Breast Lesion Localization Systems Manufacturing Base, Sales Area and Its Competitors
Table 124. STERYLAB Breast Lesion Localization Systems Product Portfolios and Specifications
Table 125. STERYLAB Breast Lesion Localization Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. STERYLAB Main Business
Table 127. STERYLAB Latest Developments
Table 128. Biomedical Basic Information, Breast Lesion Localization Systems Manufacturing Base, Sales Area and Its Competitors
Table 129. Biomedical Breast Lesion Localization Systems Product Portfolios and Specifications
Table 130. Biomedical Breast Lesion Localization Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Biomedical Main Business
Table 132. Biomedical Latest Developments
List of Figures
Figure 1. Picture of Breast Lesion Localization Systems
Figure 2. Breast Lesion Localization Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Breast Lesion Localization Systems Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Breast Lesion Localization Systems Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Breast Lesion Localization Systems Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Breast Lesion Localization Wired Systems
Figure 10. Product Picture of Breast Lesion Localization Wireless Systems
Figure 11. Global Breast Lesion Localization Systems Sales Market Share by Type in 2022
Figure 12. Global Breast Lesion Localization Systems Revenue Market Share by Type (2018-2023)
Figure 13. Breast Lesion Localization Systems Consumed in Hospital
Figure 14. Global Breast Lesion Localization Systems Market: Hospital (2018-2023) & (K Units)
Figure 15. Breast Lesion Localization Systems Consumed in Clinic
Figure 16. Global Breast Lesion Localization Systems Market: Clinic (2018-2023) & (K Units)
Figure 17. Breast Lesion Localization Systems Consumed in Medical Research Center
Figure 18. Global Breast Lesion Localization Systems Market: Medical Research Center (2018-2023) & (K Units)
Figure 19. Breast Lesion Localization Systems Consumed in Others
Figure 20. Global Breast Lesion Localization Systems Market: Others (2018-2023) & (K Units)
Figure 21. Global Breast Lesion Localization Systems Sales Market Share by Application (2022)
Figure 22. Global Breast Lesion Localization Systems Revenue Market Share by Application in 2022
Figure 23. Breast Lesion Localization Systems Sales Market by Company in 2022 (K Units)
Figure 24. Global Breast Lesion Localization Systems Sales Market Share by Company in 2022
Figure 25. Breast Lesion Localization Systems Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Breast Lesion Localization Systems Revenue Market Share by Company in 2022
Figure 27. Global Breast Lesion Localization Systems Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Breast Lesion Localization Systems Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Breast Lesion Localization Systems Sales 2018-2023 (K Units)
Figure 30. Americas Breast Lesion Localization Systems Revenue 2018-2023 ($ Millions)
Figure 31. APAC Breast Lesion Localization Systems Sales 2018-2023 (K Units)
Figure 32. APAC Breast Lesion Localization Systems Revenue 2018-2023 ($ Millions)
Figure 33. Europe Breast Lesion Localization Systems Sales 2018-2023 (K Units)
Figure 34. Europe Breast Lesion Localization Systems Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Breast Lesion Localization Systems Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Breast Lesion Localization Systems Revenue 2018-2023 ($ Millions)
Figure 37. Americas Breast Lesion Localization Systems Sales Market Share by Country in 2022
Figure 38. Americas Breast Lesion Localization Systems Revenue Market Share by Country in 2022
Figure 39. Americas Breast Lesion Localization Systems Sales Market Share by Type (2018-2023)
Figure 40. Americas Breast Lesion Localization Systems Sales Market Share by Application (2018-2023)
Figure 41. United States Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Breast Lesion Localization Systems Sales Market Share by Region in 2022
Figure 46. APAC Breast Lesion Localization Systems Revenue Market Share by Regions in 2022
Figure 47. APAC Breast Lesion Localization Systems Sales Market Share by Type (2018-2023)
Figure 48. APAC Breast Lesion Localization Systems Sales Market Share by Application (2018-2023)
Figure 49. China Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Breast Lesion Localization Systems Sales Market Share by Country in 2022
Figure 57. Europe Breast Lesion Localization Systems Revenue Market Share by Country in 2022
Figure 58. Europe Breast Lesion Localization Systems Sales Market Share by Type (2018-2023)
Figure 59. Europe Breast Lesion Localization Systems Sales Market Share by Application (2018-2023)
Figure 60. Germany Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Breast Lesion Localization Systems Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Breast Lesion Localization Systems Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Breast Lesion Localization Systems Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Breast Lesion Localization Systems Sales Market Share by Application (2018-2023)
Figure 69. Egypt Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Breast Lesion Localization Systems Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Breast Lesion Localization Systems in 2022
Figure 75. Manufacturing Process Analysis of Breast Lesion Localization Systems
Figure 76. Industry Chain Structure of Breast Lesion Localization Systems
Figure 77. Channels of Distribution
Figure 78. Global Breast Lesion Localization Systems Sales Market Forecast by Region (2024-2029)
Figure 79. Global Breast Lesion Localization Systems Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Breast Lesion Localization Systems Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Breast Lesion Localization Systems Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Breast Lesion Localization Systems Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Breast Lesion Localization Systems Revenue Market Share Forecast by Application (2024-2029)

※参考情報

乳房病変位置同定装置は、乳がん検診や治療において重要な役割を担う医療機器の一つです。この装置は、乳房内部の病変の正確な位置を特定し、適切な治療や手術を支援するために使用されます。今回は、これらの装置の概念、特徴、種類、用途、関連技術について詳しく解説します。

乳房病変位置同定装置の定義は、乳房内に存在する異常（腫瘤や病変など）を特定し、その具体的な位置を示すための道具や技術の総称です。これらの装置は、乳腺内の良性または悪性の病変を迅速かつ正確に識別し、医師が診断や治療計画を立てる手助けをします。

この装置の特徴としては、まず高精度な位置決定能力が挙げられます。さまざまな医療イメージング技術と連携して使用され、例えばマンモグラフィーや超音波検査の結果に基づいて病変の位置を特定します。また、視覚的に確認できるアウトプットを提供し、医師が病変の位置を類推するのを助けます。

次に、非侵襲的または低侵襲的な性質が特徴です。多くの装置は患者に対する負担を最小限に抑えることを目的としており、手術を行う前に病変の位置を特定することで、必要以上の切開を避けることができます。これにより、術後の回復が早まるという利点もあります。

乳房病変位置同定装置にはいくつかの種類があります。主なものとして、ワイヤーローカライゼーション装置、吸引生検装置、マーカー挿入装置、そしてナビゲーションシステムが挙げられます。ワイヤーローカライゼーションでは、病変が特定された後、細いワイヤーを挿入し、そのワイヤーを目印にして外科医が病変を取り除くことができます。この方法は、特に小型の腫瘤や位置が特定しにくい場合に有効です。

吸引生検装置は、乳房内の異常組織を採取するための装置です。この装置は、超音波ガイドまたはマンモグラフィーガイドで病変を視覚化し、細胞や組織サンプルを採取します。生検を行うことで、良性か悪性かの診断が可能になり、その後の治療に必要な情報が得られます。

マーカー挿入装置は、病変の位置を特定した後に、体内に永久的なマーカーを留置するためのもので、これにより手術が行われる場合に病変を正確に指し示すことができます。マーカーは生体適合性材料で作られ、患者の体内に長期間留まることが可能です。

ナビゲーションシステムは、最先端技術を活用し、画像処理技術と連携して病変の位置を三次元的に把握することができます。このシステムは、特に複雑な病変の場合や多発性の病変がある場合に有効であり、手術の精度向上に寄与します。

乳房病変位置同定装置の用途は多岐にわたります。主な用途は、乳がんの早期発見や診断、そして治療を行う際のガイドラインとして機能します。特に外科手術において、病変が正確に特定されることは、手術の成否を左右する重要な要素となります。

また、乳房病変位置同定装置は、診断目的だけでなく、治療計画の立案や治療効果のモニタリングにおいても重要です。治療後のフォローアップとして病変の状態を確認するために、これらの装置を利用することもあります。これにより、再発や転移のリスクを早期に把握することができます。

関連技術としては、医療用画像処理技術や機械学習が挙げられます。これらの技術は、乳房病変の定量的評価や予測に役立ち、病変の性質をより正確に理解するために必要不可欠です。近年では、AI（人工知能）を活用した診断支援システムも登場し、乳がんの早期発見に寄与しています。

さらに、バイオマーカーや遺伝子検査技術の進展により、乳がんのリスク評価や治療法の選択において、より個別化されたアプローチが可能となっています。このように、乳房病変位置同定装置は、これらの関連技術と連携しながら進化しており、より高精度かつ効率的な診断・治療を目指しています。

最後に、乳房病変位置同定装置は今後ますます重要性を増すと考えられます。高齢化社会の進展や乳がんの罹患率の上昇に伴い、早期の発見と治療が求められる中で、この装置の役割はますます重要になるでしょう。新たな技術の導入や改良が進む中、乳房病変位置同定装置は乳がん治療の質をより高めるための不可欠な存在であり続けると期待されています。


★調査レポート[世界の乳房病変位置同定装置市場予測 2023年-2029年] (コード：LP23MY4249)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の乳房病変位置同定装置市場予測 2023年-2029年]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆